ResearcherUniversity of ChicagoActive in the last 2 years

Peng Xia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6046-3790; OpenAlex author ID A5101719122. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 3

Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-025-07720-y ↗
Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the… Co-author DOI 10.1021/acsnano.3c07002 ↗
Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cells. Co-author DOI 10.1016/j.bbrc.2019.11.167 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chengming Qu · 2 shared papers, 2024–2025 · strength 0.39
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y ↗
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002 ↗
Ming Tian · 2 shared papers, 2024–2025 · strength 0.39
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y ↗
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002 ↗
Yufeng Yuan · 2 shared papers, 2024–2025 · strength 0.39
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y ↗
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002 ↗
Tianyin Ma · 1 shared paper, 2025 · strength 0.21
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y ↗
Jie Liu · 1 shared paper, 2025 · strength 0.21
- Paper Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreati… DOI 10.1038/s41419-025-07720-y ↗
Tengxiang Chen · 1 shared paper, 2024 · strength 0.18
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002 ↗
Zhiyong Yang · 1 shared paper, 2024 · strength 0.18
- Paper Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic D… DOI 10.1021/acsnano.3c07002 ↗
Tao Qin · 1 shared paper, 2020 · strength 0.11
- Paper Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cel… DOI 10.1016/j.bbrc.2019.11.167 ↗
Hongwei Zhang · 1 shared paper, 2020 · strength 0.11
- Paper Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cel… DOI 10.1016/j.bbrc.2019.11.167 ↗
Qiankun Luo · 1 shared paper, 2020 · strength 0.11
- Paper Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cel… DOI 10.1016/j.bbrc.2019.11.167 ↗
Pan Liu · 1 shared paper, 2020 · strength 0.11
- Paper Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cel… DOI 10.1016/j.bbrc.2019.11.167 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.